Jingfang Pharmaceutical-B (02595): As of November 6, a total of 2.9078 million H shares had been repurchased

Zhitongcaijing · 5d ago

According to the Zhitong Finance App, Jingfang Pharmaceutical-B (02595) announced that as of November 6, 2026, the Company has carried out a series of H share repurchases at the Hong Kong Stock Exchange Limited, with a total repurchase of 2.9078 million H shares (share repurchases), accounting for about 0.757% of the total issued share capital of the Company as of the date of this announcement.

The Company may evaluate market conditions and continue to implement its 2026 H share repurchase plan.